相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
33
- 英文名:
BAN ORL 24 (hydrochloride)
- CAS号:
1401463-54-4
- 供应商:
上海莼试
- 保存条件:
-20°C
- 规格:
1 mg 5 mg 10 mg 25 mg
| 货号 | CS-01Y75949 | 规格 | 1 mg 5 mg 10 mg 25 mg |
| CAS号 | 1401463-54-4 | 分子量 | 506.5 |
| 含量 | >98.00% | 别名 | N/A |
| 分子式 | C27H35N3O2·2HCl | 化学名 | N/A |
| 产地 | 国产 | 用途 | 仅供科研研究实验 |
分子式:C27H35N3O2·2HCl
分子量:506.5
溶解度:DMSO: Soluble,Water: Soluble
储存条件:-20°C
General tips:For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition:Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request
BAN ORL 24 is an antagonist of the nociceptin (NOP) receptor (Ki = 0.24 nM in a radioligand binding assay using CHO cell membranes expressing the human receptor).1 It is selective for NOP receptors over μ-, δ-, and κ-opioid receptors (Kis = 0.19, 0.34, and >1 μM, respectively). BAN ORL 24 reduces NOP-induced GTPγS binding (pA2 = 9.98) and calcium mobilization (KB = 0.93 nM) in CHO cells. It inhibits electrically induced twitches in isolated mouse and rat vas deferens, as well as isolated guinea pig ileum, when used at a concentration of 100 nM. BAN ORL 24 (10 mg/kg) reverses thermal and mechanical antinociceptive activities induced by the dual agonist of μ-opioid and NOP receptors BPR1M97 in mice.21.Fischetti, C., Camarda, V., Rizzi, A., et al.Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24Eur. J. Pharmacol.614(1-3)50-57(2009) 2.Chao, P.-K., Chang, H.-F., Chang, W.-T., et al.BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphieNeuropharmacology166107678(2020).
注意事项:
抗逆滴加序列
每次向板内滴加抗原时,移液器滴头要与平面45度悬空,不要触碰到孔内的液体,由后向前依次滴加(即浓度由低往高滴加)。
抗感染反应期
抗原抗体在室温20~25℃下,必须反应30min以上,若环境温度低于室温,可将微量反应板置于恒温培养箱中,使二者充分反应。
旅游温度
磷酸盐缓冲液的pH值要在高压灭菌后进行滴定,往往在高压后pH值会有所改变,所以高压后再调一次pH值更为准确。磷酸盐缓冲液一经使用保存期不要超过3周。当pH<5.8时,红细胞会产生自凝现象;当pH>7.8时,图形洗脱加快,易造成肉眼观察产生误差;p H=7.2时,红细胞沉降最充分,图形最清晰。
当滴注 1%红细胞悬液时,应经常摇晃红细胞悬液,使红细胞均匀地分布在磷酸缓冲液中,以防止红细胞下降。
反应时间及温度
加入鸡红血球之后,反应板在室温(20~25℃)静置30~40min,对照孔血球下沉于孔底,即可判定结果。若室温达不到实验要求,需相应调整反应时间。当环境温度低于4℃时,红细胞发生自凝;高于37℃时,会发生反应物分离和红细胞溶血。
使用方法:
1.本蛋白酶抑制剂混合物为100×的储存液,使用时按照1:100的比例加入到裂解液中(例如,1ml裂解液中加入10μl蛋白酶抑制剂混合物),混匀后即可使用。根据需要,0.5M的EDTA也按照1:100的比例加入到裂解液中(如用于检测金属蛋白酶活性,则不宜添加EDTA)。含有蛋白酶抑制剂混合物的裂解液宜现用现配,不宜配制后冻存待后续使用。
2. 待所需的抑制剂添加完毕混匀后,就可以开始进行哺乳动物组织的裂解和蛋白提取。
公司正在出售的产品:
| Z-Tyr-OtBu.H2O | FFN 200 dihydrochloride |
| AZD9056 hydrochloride | 酪氨酸蛋白激酶受TYRO3(TYRO3)检测试剂盒 |
| Thiocolchicoside | 狼疮抗凝抗(LAC/LA)检测试剂盒 |
| KS 176 | 兰尼碱抗检测试剂盒 |
| ML SA1 | 兰尼碱受2(RYR2)检测试剂盒 |
| PYD-106 | 赖氨酰氧化酶(LOX)检测试剂盒 |
| CM-4620 | 赖氨酸特异性脱甲基酶5A(JARID1A)检测试剂盒 |
| (R)-Posenacaftor sodium | Mouse Ubiquitin, Ub Elisa Kit |
| Spinosyn D | 酪氨酸羟化酶(TH)检测试剂盒 |
| Chlorpromazine D6 hydrochloride | 酪氨酰DNA磷酸二酯酶1(TDP1)检测试剂盒 |
| CLP 257 | 酪氨酰tRNA合成酶(YARS)检测试剂盒 |
| AR-C 141990 hydrochloride | 雷帕霉素靶蛋白(mTOR)检测试剂盒 |
| Ralfinamide | BAN ORL 24 (hydrochloride)类白细胞抗原A(HLA-A)检测试剂盒 |
| (R)-(+)-HA-966 | 类白细胞抗原B27(HLA-B27)检测试剂盒 |
| 类白细胞抗原G(HLA-G)检测试剂盒 | 类白细胞抗原C(HLA-C)检测试剂盒 |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Cloning New Small RNA Sequences
silencing pathway. These endogenous and exogenous small RNAs are mainly 21-24 nucleotides in length. Here, we describe a method to identify small RNA sequences from plant tissues. Small RNAs are purified by column fractionation and gel excision from total
MicroRNA和siRNA克隆规程(MicroRNA and siRNA Cloning Protocol)
RNA Cloning Method Flowchart Extract total RNA containing small RNAs. Check quality on denaturing gel with EtBr staining 5" End label RNA markers 18.113 (18mer) and 44.12 (24mer
A Simple and Reliable Assay of Proteoglycan Synthesis by Cultured Chondrocytes
A simple and reliable method to measure proteoglycan synthesis by chondrocytes in culture is described. Confluent chondrocytes in 24-well plates are labeled for 24–72 h with 35 SO4 2− in the presence of stimulating agents. At the end
技术资料暂无技术资料 索取技术资料








